Candelaria Mining Corp. — AGM Information 2021

Nov 19, 2021

==> picture [226 x 58] intentionally omitted <==

Suite 1201 - 1166 Alberni Street Vancouver, British Columbia Canada, V6E 3Z3

NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS

NOTICE is hereby given that an annual general meeting of the shareholders (the “Shareholders”) of Candelaria Mining Corp. (the “Company”) will be held at Suite 1201 - 1166 Alberni Street, Vancouver, British Columbia, V6E 3Z3 on Thursday, December 16, 2021 at 10:00 am, local time, (the “Meeting”).

The Meeting is held for the following purposes:

1. to receive the financial statements for the year ended April 30, 2021, together with the auditor’s report thereon and the related management discussion and analysis;

2. to elect directors of the Company for the ensuing year;

3. to appoint Grant Thornton LLP, as auditor of the Company for the ensuing year and authorize the directors to determine their remuneration; and

4. to approve the Company’s stock option plan for continuation.

An Information Circular accompanies this Notice. The Information Circular contains details of matters to be considered at the Meeting. No other matters are contemplated, however any permitted amendment to or variation of any matter identified in this Notice may properly be considered at the Meeting. The Meeting may also consider the transaction of such other business as may properly come before the Meeting or any adjournment thereof.

Copies of the audited financial statements for the fiscal year ended April 30, 2021, the report of the auditor thereon, and the related management discussion and analysis will be made available at the Meeting and are available at www.sedar.com under the Company’s profile.

At the date of this Notice and the accompanying Information Circular, it is the intention of the Company to hold the Meeting at the location stated above in this Notice. However, the Company is continuously monitoring developments of the current coronavirus (COVID-19) outbreak (“ COVID-19 ”). In light of the rapidly evolving public health guidelines related to COVID-19, we ask shareholders to consider voting their shares by proxy and not attend the meeting in person . Those shareholders who do wish to attend the Meeting in person should carefully consider and follow the instructions of the federal Public Health Agency of Canada available at: https://www.canada.ca/en/public-health/services/diseases/coronavirus-diseasecovid-19.html. We ask that shareholders also review and follow the instructions of any regional health authorities of the Province of British Columbia, including the Vancouver Coastal Health Authority, the Fraser Health Authority and any other health authority holding jurisdiction over the areas you must travel through to attend the Meeting. Do not attend the Meeting in person if you are experiencing any cold or flu-like symptoms, or if you or someone with whom you have been in close contact has travelled to/from outside of Canada within the 14 days immediately prior to the Meeting. All shareholders are strongly encouraged to vote by submitting their completed form of proxy (or voting instruction form) prior to the Meeting by one of the means described in the Information Circular accompanying this Notice.

The Company reserves the right to take any additional precautionary measures deemed to be appropriate, necessary or advisable in relation to the Meeting in response to further developments in the COVID-19 outbreak, including: (i) holding the Meeting virtually or by providing a webcast of the Meeting; (ii) hosting the Meeting solely by means of remote communication; (iii) changing the Meeting date and/or changing the means of holding the Meeting; (iv) denying access to persons who exhibit cold or flu-like symptoms, or who have, or have been in close contact with someone who has travelled to/from outside of Canada within the 14 days immediately prior to the Meeting; (v) denying access to persons that do not have evidence of

• 2 -

full vaccination or a negative COVID-19 rapid test result completed within 24 hours immediately prior to the Meeting, and (vi) such other measures as may be recommended by public health authorities in connection with gatherings of persons such as the Meeting. Should any changes to the Meeting format occur, the Company will announce any and all of these changes by way of news release, which will be filed under the Company’s profile on SEDAR. We strongly recommend you check the Company’s SEDAR profile prior to the Meeting for the most current information. In the event of any changes to the Meeting format due to the COVID-19 outbreak, the Company will NOT prepare or mail amended Meeting Proxy Materials.

Shareholders who are unable to attend the Meeting in person and who wish to ensure that their shares will be voted at the Meeting are requested to complete, date and sign the enclosed form of proxy, or another suitable form of proxy, and deliver it by fax, by hand or by mail in accordance with the instructions set out in the form of proxy and in the Information Circular.

Non-registered Shareholders who are unable to attend the Meeting and who wish to ensure that their shares will be voted at the Meeting must follow the instructions set out in the form of proxy or voting instruction form and in the Information Circular to ensure that their shares will be voted at the Meeting. If you hold your shares in a brokerage account you are a non-registered shareholder.

In view of the precautions required with respect to COVID, any shareholder who wishes to attend the Meeting in person must contact the Company at least 48 hours prior to the Meeting at (604) 328-5598.

DATED at Vancouver, British Columbia, as at November 8, 2021.

BY ORDER OF THE BOARD OF DIRECTORS OF THE COMPANY

“Michael Struthers”

Michael Struthers

Chief Executive Officer